BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results
European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)
We crunch the numbers to see which stocks are most widely held among analyst-recommended large-cap funds.
Ownership data provide a look at who else owns the company.
Standing out in a good year for stocks.
Week ending Nov. 10: Investors remain optimistic about direction of economy.
Buying a country or sector fund isn't as easy as it seems.